General Biologicals Corporation announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 164.834 million compared to TWD 125.561 million a year ago. Operating loss was TWD 2.140 million compared to TWD 18.483 million a year ago. Net loss was TWD 2.571 million compared to TWD 20.786 million a year ago. Basic loss per share was TWD 0.05 compared to TWD 0.53 a year ago.